On-Demand Webinars

  1. Enhancing mRNA-LNP Downstream Processing Via Single-Pass TFF 9/2/2026

    Single-pass tangential flow filtration effectively concentrates mRNA-LNPs and removes ethanol while maintaining quality. See how this approach produced LNPs with 4.2-fold higher in vitro potency.

  2. How Cell Therapy's Fundamentally Different Model Impacts Patients 9/1/2026

    Examine the evolution of autologous CAR T therapies, their patient-specific manufacturing workflow, key similarities and differences with biologics production, and real-world approaches.

  3. Viral Safety Considerations In Process Development 9/1/2026

    Explore how upstream media filtration and downstream anion exchange chromatography can work together to manage viral risk, strengthen AAV process development, and support reliable GMP production.

  4. Genomic Medicine At An Inflection Point 9/1/2026

    In vivo therapies and streamlined ex vivo manufacturing are redefining genomic medicine. Understand the tradeoffs, priorities, and technical challenges influencing how future treatments are designed.

  5. A Practical Roadmap For Column Sizing, System Selection, And GxP Readiness 9/1/2026

    Chromatography scale-up depends on aligning different factors. Learn which factors can help maintain process consistency, manage risk, and support the transition from development to manufacturing.

  6. Faster Paths To Biosimilar Equivalence: Turning Guidance Into An Advantage 9/1/2026

    Evolving biosimilar guidance creates opportunities to reduce comparative clinical requirements through strong analytical evidence, risk-based justification, structure-function knowledge, and more.

  7. Chromatography Polishing In The Age Of Intensification 9/1/2026

    As upstream processes intensify, chromatography polishing must handle higher loads and evolving impurity profiles. Modern strategies can improve clearance, extend resin life, and maintain throughput.

  8. How Perfusion In Seed Train Bioreactors Can Simplify Upstream Processes 9/1/2026

    N-1 perfusion achieved approximately 95% viability while scaling from bench to production. See how this approach intensified seed trains without affecting subsequent fed-batch performance.

  9. Improved Clearance Of Host Cell Proteins After Virus Inactivation 9/1/2026

    Learn how post-viral inactivation filtration can support precipitate and host cell protein removal while balancing throughput, purity and cost across different feeds and process development conditions.

  10. Using Computational Fluid Dynamics To Design Scalable Processes 8/31/2026

    Learn how CFD modeling and experimental data can be combined to assess power input, mixing, oxygen transfer, and more across bioreactor scales, supporting sound process decisions.